A. China
B. US
C. Russia
D. Japan
Background of Pfizer and the COVID-19 Vaccine
Pfizer was founded in 1849 in New York, United States, and has grown into one of the world’s largest pharmaceutical companies. During the COVID-19 pandemic, Pfizer collaborated with BioNTech to develop the Pfizer–BioNTech COVID-19 vaccine (BNT162b2), which was the first COVID-19 vaccine authorized for emergency use by several major regulatory authorities worldwide.
The vaccine utilizes mRNA technology, which teaches the body’s immune system to recognize and respond to the coronavirus without causing the disease itself. Its rapid development represented one of the most significant scientific achievements during the global pandemic.
Pfizer continues to produce medicines and vaccines for numerous diseases, including cancer, cardiovascular disorders, infectious diseases, and rare medical conditions.
Important Key Facts about Pfizer
- Founded: 1849.
- Headquarters: New York City, United States.
- COVID-19 Vaccine Partner: BioNTech (Germany).
- COVID-19 Vaccine Name: Pfizer–BioNTech (BNT162b2).
- Vaccine Technology: mRNA-based vaccine.
- Industry: Pharmaceuticals and Biotechnology.
Exam Relevance: COVID-19 Vaccines, Pfizer, BioNTech, Pharmaceutical Companies, International Organizations, Current Affairs, Global Health, CSS, PMS, FPSC, PPSC, NTS, OTS, FIA, MOD, ASF, ISSB, Lecturer Tests, and Competitive Examinations.